ArticleCureus2025
Hybrid Management of Giant Solitary Intracranial Fibrous Tumors: A Report of Two Cases.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solitary fibrous tumors (SFTs) are rare tumors of vascular origin, derived from pericytes surrounding blood vessels. Their frequency of presentation is mainly in adults, and they can be in various parts of the body, such as the extremities, head, neck, retroperitoneum, and abdomen. These tumors can be either benign or malignant, and their behavior and clinical course are variable, with a significant risk of recurrence and metastasis. We present a two-case report: the first involving a 25-year-old man with right hemiparesis and a history of two prior surgeries at another institution for a diagnosed SFT; the second involving a 48-year-old man with decreased visual acuity and personality changes, with a biopsy confirming SFT. Both cases were managed with embolization followed by resection, with no residual tumor remaining. Treatment of SFTs with embolization and complete surgical resection improves surgical outcomes and reduces the risk of recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.